article thumbnail

The 2025 Pharma Toolkit for Virtual Medical Education

Impetus Digital

Pharma-exclusive Webinar: The 2025 Pharma Toolkit for Virtual Medical Education About the webinar Step into the future of medical education with our exclusive webinar series from February 25-26, designed specifically for Pharma leaders. Secure your front-row seat to the future of medical education and training.

Education 110
article thumbnail

Polypharmacy is a Health Killer: Personalized Medication Management is the Answer

MedCity News

The post Polypharmacy is a Health Killer: Personalized Medication Management is the Answer appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Astellas Exec Talks Dealmaking and Pipeline Strategy in Cancer, Gene Therapy & More

MedCity News

Astellas Pharma still looks to grow in cancer with a pipeline that includes internally developed programs that could stand out in oncology. But the drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguci said.

Pharma 273
article thumbnail

Novo Nordisk Bets $200M on Triple-Targeting Drug for Obesity and Other Metabolic Diseases

MedCity News

Separately, the pharma giant said its recently announced discounted price for obesity medication Wegovy is now expanding to traditional pharmacies. Novo Nordisk is licensing rights to a United Biotechnology drug that sparks metabolic effects by binding to and activating receptors for GLP-1, GIP, and glucagon.

Pharma 229
article thumbnail

Shifting Focus from Medication Costs to Medication Value

MedCity News

To realize true, sustainable savings in total cost of care, the healthcare system needs to reconsider the support — or lack of support — it provides throughout patients’ medication experiences and the snowball effect that creates on a lifetime of healthcare costs.

Medical 290
article thumbnail

A Wearable Tech Gives Pharmas & Therapists Better Feel for Changes in Mental Health

MedCity News

Pharmaceutical companies use Feel Therapeutics’ technology to monitor the mental state of participants in clinical trials of behavioral medications. The post A Wearable Tech Gives Pharmas & Therapists Better Feel for Changes in Mental Health appeared first on MedCity News.

Pharma 331
article thumbnail

Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New Rare Disease Site

MedCity News

Separately, the pharma giant said all regulatory conditions have been met for Novo Holdings acquisition of Catalent, which will bring to Novo Nordisk three manufacturing sites for GLP-1 medications. Novo Nordisks new Denmark site will produce drugs for rare diseases, such as hemophilias.